A new treatment for mesothelioma cancer utilizing microRNA is in
the midst of being studied by Rosetta Genomics and New York University Langone
Medical Center.
The microRNA involved in the study is miR-31. Researchers believe
that this could be the answer mesothelioma victims and doctors have been
looking for to treat the asbestos-caused cancer. MicroRNA has already shown to
reduce the development of tumors and suppress the spread of breast cancer.
President and CEO of Rosetta Genomics, Kenneth A. Berlin, notes
the significance the study could have for the treatment of the deadly cancer.
“Over the past several years, microRNAs have been hailed as one of the most significant
scientific and medical discoveries. They have been described as the body’s
‘master switches,’ holding significant potential for therapeutic applications
and have been shown to be highly sensitive and specific biomarkers. This latest
publication is another demonstration of microRNAs’ potential role in cancer
therapeutics and details the significant impact a single microRNA can have on
disease course.”
The probability that mesothelioma patients will survive the
disease is unlikely. If diagnosed within the first 12 months of developing
initial symptoms, chances of survival improve but are not guaranteed. Current
treatments include radiation therapy and surgery but many have failed to help
those who have had the disease for an extended period of time. The use of
microRNA could mean the end of suffering for mesothelioma victims and their
families.
If you have mesothelioma or believe you may be at risk for
developing the cancer, obtain legal counsel from a mesothelioma lawyer immediately in order to receive compensation
for your disease. A mesothelioma lawyer will
contact former and current employers, find medical coverage for you and stand
by you in your fight against the cancer. The longer you wait to seek help, the
less your chances of beating mesothelioma.
